Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Top Research Reports for Berkshire Hathaway, Exxon Mobil & Pfizer
05:24pm, Monday, 19'th Dec 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BR.B), Exxon Mobil Corporation (XOM) and Pfizer Inc. (PFE).
1 Passive Income Stock to Buy Today, and 1 to Avoid for Now
03:00pm, Sunday, 18'th Dec 2022 The Motley Fool
Rising interest rates don't affect all passive income stocks equally.
2022 Bargain Shopping: 2 Smart Stocks to Buy Before the New Year
11:30am, Sunday, 18'th Dec 2022 The Motley Fool
These stocks look cheap -- especially considering their long-term potential.
1 Passive Income Stock to Buy Today, and 1 to Avoid for Now
10:00am, Sunday, 18'th Dec 2022
Rising interest rates don't affect all passive income stocks equally.
2022 Bargain Shopping: 2 Smart Stocks to Buy Before the New Year
06:30am, Sunday, 18'th Dec 2022
These stocks look cheap -- especially considering their long-term potential.
Want $250 in Passive Income? Buy These 2 Dividend Kings and Wait
02:53pm, Friday, 16'th Dec 2022 The Motley Fool
These companies will work hard to grow your base of passive income.
2 Dividend Stocks That Could Double Your Return in 10 Years
10:05am, Friday, 16'th Dec 2022 The Motley Fool
Both companies should hurdle their patent cliff concerns.
2 Top Dividend Stocks to Buy Hand Over Fist Before 2023
10:00am, Friday, 16'th Dec 2022 The Motley Fool
These stocks will bring you income -- no matter what the market is doing.
Want $250 in Passive Income? Buy These 2 Dividend Kings and Wait
09:53am, Friday, 16'th Dec 2022
These companies will work hard to grow your base of passive income.
2 Top Dividend Stocks to Buy Hand Over Fist Before 2023
05:00am, Friday, 16'th Dec 2022
These stocks will bring you income -- no matter what the market is doing.
Why Abbott Laboratories Topped the Market on Tuesday
11:55pm, Tuesday, 13'th Dec 2022 The Motley Fool
Bullish momentum behind the big pharmaceutical company was aided by a glowing new analyst note.
Abbott (ABT) Outpaces Stock Market Gains: What You Should Know
10:50pm, Tuesday, 13'th Dec 2022 Zacks Investment Research
In the latest trading session, Abbott (ABT) closed at $111.53, marking a +1.86% move from the previous day.
Why Abbott Laboratories Topped the Market on Tuesday
06:55pm, Tuesday, 13'th Dec 2022
Bullish momentum behind the big pharmaceutical company was aided by a glowing new analyst note.
Reliable Passive Income: an Analysis on Dividend Kings
12:33pm, Tuesday, 13'th Dec 2022 The Motley Fool
A Dividend King is any stock that has increased its dividend for 50+ cosecutive years, doubling that of a Dividend Aristocrat.
Expert Ratings for Abbott Laboratories
06:02pm, Monday, 12'th Dec 2022 Benzinga
Analysts have provided the following ratings for Abbott Laboratories (NYSE:ABT) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
7
2
0
0
